Cargando…

PREFERENCES OF PATIENTS WITH MULTIPLE SCLEROSIS FOR ATTRIBUTES OF INJECTABLE MULTIPLE SCLEROSIS TREATMENTS IN THE UNITED KINGDOM AND FRANCE

OBJECTIVES: Adherence to injectable disease-modifying treatments in patients with multiple sclerosis (MS) impacts outcomes and can be influenced by perceptions of treatment efficacy, side effects, injection frequency, and the duration of injection. This study aimed to quantify preferences for select...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poulos, Christine, Kinter, Elizabeth, van Beek, Johan, Christensen, Katrine, Posner, Joshua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2018
Materias:	Assessment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190072/ https://www.ncbi.nlm.nih.gov/pubmed/30251947 http://dx.doi.org/10.1017/S0266462318000491

Ejemplares similares

Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment
por: Poulos, Christine, et al.
Publicado: (2015)

Patient and physician preferences for multiple sclerosis treatments in Germany: A discrete-choice experiment study
por: Poulos, Christine, et al.
Publicado: (2020)

IMPORTANCE OF MULTIPLE CRITERIA FOR PRIORITY SETTING OF HIV/AIDS INTERVENTIONS
por: Tromp, Noor, et al.
Publicado: (2015)

Smoking Attributable Risk in Multiple Sclerosis
por: Manouchehrinia, Ali, et al.
Publicado: (2022)

Recovery From COVID-19 in Multiple Sclerosis: A Prospective and Longitudinal Cohort Study of the United Kingdom Multiple Sclerosis Register
por: Garjani, Afagh, et al.
Publicado: (2021)

CONSUMER PREFERENCES FOR SCANNING MODALITY TO DIAGNOSE FOCAL LIVER LESIONS
por: Whitty, Jennifer, et al.
Publicado: (2015)

Preferences Toward Attributes of Disease-Modifying Therapies: The Role of Nurses in Multiple Sclerosis Care
por: del Río-Muñoz, Beatriz, et al.
Publicado: (2022)

Geographical Heterogeneity of Multiple Sclerosis Prevalence in France
por: Pivot, Diane, et al.
Publicado: (2016)

Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study
por: Manouchehrinia, Ali, et al.
Publicado: (2013)

Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom
por: Abdel-mannan, Omar A., et al.
Publicado: (2021)

Assessing Pharmacists’ Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis
por: Martínez-López, Iciar, et al.
Publicado: (2020)

The Multiple Sclerosis Care Unit
por: Soelberg Sorensen, Per, et al.
Publicado: (2018)

Associations of Alcohol Consumption and Smoking With Disease Risk and Neurodegeneration in Individuals With Multiple Sclerosis in the United Kingdom
por: Kleerekooper, Iris, et al.
Publicado: (2022)

Measuring the impact of multiple sclerosis: Enhancing the measurement performance of the Multiple Sclerosis Impact Scale (MSIS-29) using Rasch Measurement Theory (RMT)
por: Cleanthous, Sophie, et al.
Publicado: (2017)

Preferences for exercise among black individuals with multiple sclerosis
por: Kinnett-Hopkins, Dominique, et al.
Publicado: (2019)

HOSPITAL MANAGERS’ NEED FOR INFORMATION ON HEALTH TECHNOLOGY INVESTMENTS
por: Ølholm, Anne Mette, et al.
Publicado: (2015)

Patients’ preferences for bone metastases treatments in France, Germany and the United Kingdom
por: Hechmati, Guy, et al.
Publicado: (2014)

Physicians’ preferences for bone metastases treatments in France, Germany and the United Kingdom
por: Qian, Yi, et al.
Publicado: (2018)

REVIEWING TRANSFERABILITY IN ECONOMIC EVALUATIONS ORIGINATING FROM EASTERN EUROPE
por: Mandrik, Olena, et al.
Publicado: (2015)

Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination
por: Le Houézec, Dominique
Publicado: (2014)

Economic Burden of the Out-of-Pocket Expenses for People with Multiple Sclerosis in France
por: Heinzlef, Olivier, et al.
Publicado: (2020)

The socioeconomic impact of multiple sclerosis in France: Results from the PETALS study
por: Bouleau, A, et al.
Publicado: (2022)

Perspectives and experiences of Dutch multiple sclerosis patients and multiple sclerosis-specialized neurologists on injectable disease-modifying treatment
por: Visser, Leo H, et al.
Publicado: (2016)

P936: EXPLORING HETEROGENEITY IN TREATMENT PREFERENCES OF PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN THE UNITED STATES, UNITED KINGDOM, FRANCE, SPAIN, ITALY AND GERMANY
por: Popat, Rakesh, et al.
Publicado: (2023)

The impact of quality of life on treatment preferences in multiple sclerosis patients
por: Lee Mortensen, Gitte, et al.
Publicado: (2017)

Defining routine fatigue care in Multiple Sclerosis in the United Kingdom: What treatments are offered and who gets them?
por: Picariello, Federica, et al.
Publicado: (2022)

Impact of depression and fatigue on relapsing remitting multiple sclerosis in Kingdom of Saudi Arabia
por: Alshamrani, Foziah J., et al.
Publicado: (2020)

Natalizumab Rebound in Multiple Sclerosis
por: Lee, Joshua D., et al.
Publicado: (2021)

Intrathecal, Not Systemic Inflammation Is Correlated With Multiple Sclerosis Severity, Especially in Progressive Multiple Sclerosis
por: Milstein, Joshua L., et al.
Publicado: (2019)

Multiple sclerosis /
por: Warren, Sharon
Publicado: (2001)

MULTIPLE SCLEROSIS
Publicado: (1955)

MULTIPLE SCLEROSIS
Publicado: (1971)

Multiple Sclerosis
por: Ramagopalan, Sreeram, et al.
Publicado: (2011)

Multiple Sclerosis
por: Gaby, Alan
Publicado: (2013)

Multiple Sclerosis
por: Zinder, Oren
Publicado: (2004)

Multiple Sclerosis
por: Lane, Michael, et al.
Publicado: (2020)

Multiple sclerosis
por: Lynch, Sharon G., et al.
Publicado: (1996)

Multiple sclerosis
por: Klocke, Shilpa, et al.
Publicado: (2019)

Multiple Sclerosis
por: Lobeck, Lorri J.
Publicado: (2002)

Multiple Sclerosis
por: Karussis, Dimitrios
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a4st2ojolmfvorte5rmiv92t5i